DL
MSACW

Daniel Loeb’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Daniel Loeb’s Portfolio MSACW Stock Details MSACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-87,774
Closed -$62K – 122
2021
Q3 		$62K Hold
87,774
– – ﹤0.01% 113
2021
Q2 		$89K Buy
+87,774
New +$69.5K ﹤0.01% 126

Other funds holding MSACW

DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Daniel Loeb's MSACW Position: Q4 2021 in Review

Daniel Loeb sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q4 2021, closing a stake of 87,774 shares — an estimated $62K sold.

Daniel Loeb first reported a position in MSACW in Q2 2021 and held it in 2 quarters. The position peaked at $89K in Q2 2021. 16 funds tracked by Wall St. Rank hold MSACW as of Q4 2021.

  • Daniel Loeb reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q4 2021 after selling out during the quarter.
  • Daniel Loeb sold 87,774 Medicus Sciences Acquisition Corp. Warrant shares in Q4 2021, an estimated $62K.
  • Daniel Loeb first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 2 quarters.
  • Daniel Loeb's Medicus Sciences Acquisition Corp. Warrant position peaked at $89K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q4 2021.

Based on Third Point's 13F filing for Q4 2021, filed 14 Feb 2022.